American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.
Jeffrey R CurtisSindhu R JohnsonDonald D AnthonyReuben J ArasaratnamLindsey R BadenAnne R BassCassandra CalabreseEllen M GravalleseRafael HarpazAndrew KrogerRebecca E SadunAmy S TurnerEleanor Anderson WilliamsTed R MikulsPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
These guidance statements, made in the context of limited clinical data, are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients.
Keyphrases
- coronavirus disease
- healthcare
- sars cov
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- primary care
- rheumatoid arthritis
- juvenile idiopathic arthritis
- prognostic factors
- patient reported outcomes
- electronic health record
- machine learning
- respiratory syndrome coronavirus
- systemic lupus erythematosus
- patient reported
- psychometric properties
- data analysis